153 related articles for article (PubMed ID: 359394)
1. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
Eff C; Faber O; Deckert T
Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
[TBL] [Abstract][Full Text] [Related]
2. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
3. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus.
Frier BM; Faber OK; Binder C; Elliot HL
Diabetologia; 1978 May; 14(5):301-4. PubMed ID: 348540
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
Hendriksen C; Faber OK; Drejer J; Binder C
Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
[TBL] [Abstract][Full Text] [Related]
5. The influence of supervision and endogenous insulin secretion on the course of insulin-dependent diabetes mellitus.
Deckert T
Acta Endocrinol Suppl (Copenh); 1980; 238():31-8. PubMed ID: 7001837
[TBL] [Abstract][Full Text] [Related]
6. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
[TBL] [Abstract][Full Text] [Related]
7. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
[TBL] [Abstract][Full Text] [Related]
8. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ
Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119
[TBL] [Abstract][Full Text] [Related]
9. The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.
Lutterman JA; Benraad TJ; van 't Laar A
Diabetologia; 1981 Aug; 21(2):99-102. PubMed ID: 7021291
[TBL] [Abstract][Full Text] [Related]
10. [Effect of i.v. tolbutamide on alpha- and beta-cell secretion in type I diabetes].
Verga S; Donatelli M; Cerasola G; Sinagra D; Inglese CG; Terrizzi C
Minerva Endocrinol; 1984; 9(3):339-42. PubMed ID: 6398400
[No Abstract] [Full Text] [Related]
11. C-peptide response to arginine infusion in insulin requiring diabetics.
Fujii S; Tanaka S; Akai T; Ueda N; Nakatani K; Seki J; Wada M
Osaka City Med J; 1978; 24(1):25-32. PubMed ID: 377185
[No Abstract] [Full Text] [Related]
12. [Insulin reserve of insulin-dependent diabetics. Role of C-peptide in the hormonal balance in diabetes].
Dauzat J; Moinade S; Gaillard G; Glanddier Y; Gachon AM
Presse Med; 1983 Sep; 12(32):1983-7. PubMed ID: 6225101
[TBL] [Abstract][Full Text] [Related]
13. Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.
Garcia-Webb P; Bonser A; Welborn TA
Diabetologia; 1982 Apr; 22(4):296. PubMed ID: 7047275
[No Abstract] [Full Text] [Related]
14. C-peptide in juvenile diabetes.
Ludvigsson J; Heding LG
Acta Paediatr Scand Suppl; 1977; (270):53-62. PubMed ID: 356517
[TBL] [Abstract][Full Text] [Related]
15. Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
Björk E; Berne C; Kämpe O; Wibell L; Oskarsson P; Karlsson FA
Diabetes; 1996 Oct; 45(10):1427-30. PubMed ID: 8826981
[TBL] [Abstract][Full Text] [Related]
16. beta-cell function in children with diabetes.
Ludvigsson J; Heding LG
Diabetes; 1978; 27 Suppl 1():230-4. PubMed ID: 344114
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell function and diabetic control in insulin dependent diabetes melletus.
Faber OK
Acta Endocrinol Suppl (Copenh); 1985; 272():73-7. PubMed ID: 3914807
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
19. [Assay of C-peptide in diabetes in children and adolescents].
Jos J; Kestenbaum S
Ann Med Interne (Paris); 1984; 135(6):416-9. PubMed ID: 6391322
[TBL] [Abstract][Full Text] [Related]
20. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
